RTL
LGND icon

Red Tortoise LLC’s Ligand Pharmaceuticals LGND Stock Holding History

Red Tortoise LLC’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.99K Hold
35
– – ﹤0.01% 340
2025
Q4 		$6.62K Hold
35
– – ﹤0.01% 345
2025
Q3 		$6.2K Hold
35
– – ﹤0.01% 349
2025
Q2 		$3.98K Hold
35
– – ﹤0.01% 399
2025
Q1 		$3.68K Hold
35
– – ﹤0.01% 398
2024
Q4 		$3.75K Hold
35
– – ﹤0.01% 403
2024
Q3 		$3.5K Hold
35
– – ﹤0.01% 421
2024
Q2 		$2.95K Hold
35
– – ﹤0.01% 440
2024
Q1 		$2.56K Hold
35
– – ﹤0.01% 469
2023
Q4 		$2.5K Buy
+35
New +$2.06K ﹤0.01% 423

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Red Tortoise LLC's LGND Position: Q1 2026 in Review

Red Tortoise LLC held its Ligand Pharmaceuticals (LGND) position steady in Q1 2026 at 35 shares worth $6.99K. The position accounts for ﹤0.01% of the portfolio, ranked #340.

Red Tortoise LLC first reported a position in LGND in Q4 2023 and has held it in 10 quarters since. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Red Tortoise LLC held 35 shares of Ligand Pharmaceuticals worth $6.99K as of Q1 2026.
  • Red Tortoise LLC left its Ligand Pharmaceuticals share count unchanged in Q1 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of Red Tortoise LLC's portfolio in Q1 2026, its #340 holding.
  • Red Tortoise LLC first reported a position in Ligand Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Red Tortoise LLC's 13F filing for Q1 2026, filed 21 Apr 2026.